Related Experiment Video
Updated: Mar 10, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Do different organ involvements cause different comorbidity profiles in Behçet's syndrome?
Bahar Özdemir Ulusoy1, Esra Kayacan Erdoğan2, Berkan Armağan2
1Department of Rheumatology, Ankara Gaziler Physical Therapy and Rehabilitation Training and Research Hospital, Ankara, Türkiye.
Vascular involvement in Behçet's syndrome (BS) significantly increases cardiovascular disease (CVD) risk. This highlights the need for tailored management strategies based on specific patient presentations.
Area of Science:
- Rheumatology
- Internal Medicine
- Clinical Epidemiology
Background:
- Behçet's syndrome (BS) is a multisystemic inflammatory disorder.
- Understanding comorbidity profiles associated with specific organ involvement in BS is crucial for patient management.
Purpose of the Study:
- To investigate the association between different organ involvements in Behçet's syndrome and distinct comorbidity profiles.
- To identify if specific organ involvement predicts cardiovascular disease (CVD) in BS patients.
Main Methods:
- Retrospective cohort study of 345 patients meeting International Study Group criteria for BS.
- Patients categorized into Vascular, Mucocutaneous, and 'Others' organ involvement groups.
- Comorbidity data analyzed using binomial logistic regression, adjusting for hypertension, diabetes mellitus, and hyperlipidemia.
Main Results:
- The Vascular group exhibited the highest comorbidity rate (59.8%), with a significant increase in cardiovascular comorbidities (coronary artery disease, stroke).
- No significant differences in diabetes mellitus, hyperlipidemia, or hypertension were observed across groups.
- Vascular involvement independently predicted CVD, even after adjusting for other risk factors.
Conclusions:
- Vascular involvement in Behçet's syndrome is linked to a higher burden of cardiovascular comorbidities.
- Vascular involvement serves as an independent predictor of CVD in BS patients.
- Findings suggest the necessity for tailored management strategies based on clinical presentation in BS.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

